Home/Filings/4/0000899243-21-048204
4//SEC Filing

PETERSON RICHARD D 4

Accession 0000899243-21-048204

CIK 0001817944other

Filed

Dec 13, 7:00 PM ET

Accepted

Dec 14, 7:00 PM ET

Size

7.7 KB

Accession

0000899243-21-048204

Insider Transaction Report

Form 4
Period: 2021-12-11
PETERSON RICHARD D
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2021-12-11+55,80055,800 total
  • Award

    Stock Option (Right to Buy)

    2021-12-11+139,500139,500 total
    Exercise: $4.78Exp: 2031-12-10Common Stock (139,500 underlying)
Footnotes (2)
  • [F1]The Reporting Person was granted a Restricted Stock Unit under the Issuer's 2021 Stock Option and Incentive Plan (the "2021 Plan") for 55,800 shares on 12/11/2021, of which 25% vest on 9/9/2022, and the remaining shares vest in 36 equal monthly installments thereafter subject to the Reporting Person continuing to have a service relationship as of each such vesting date.
  • [F2]These options were granted under the 2021 Plan and vest (i) 25% on 9/9/2022 and (ii) with the remainder vesting in 36 equal monthly installments thereafter subject to the Reporting Person continuing to have a service relationship as of each such vesting date.

Issuer

Clarus Therapeutics Holdings, Inc.

CIK 0001817944

Entity typeother

Related Parties

1
  • filerCIK 0001430423

Filing Metadata

Form type
4
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 7:00 PM ET
Size
7.7 KB